Donor-Derived Cell-Free DNA as a Non-Invasive Readout of Activity Across the Rejection Continuum
Transplant International · 24.02.2026 · 39
DOI: 10.3389/ti.2026.16099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant International, online erschienen am 24.02.2026. Verfasst von Louise Benning und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany. Hauptthemen laut MEDLINE: Graft Rejection, Cell-Free Nucleic Acids, Kidney Transplantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Recent work demonstrated that kidney allograft rejection unfolds along a biological continuum that can be quantified using histopathology-derived continuous indices. To investigate whether donor-derived cell-free DNA (dd-cfDNA) reflects this rejection continuum and complements these histopathology-derived indices, we analyzed the association between dd-cfDNA measures and the newly developed rejection indices in 249 indication biopsies from two independent cohorts. dd-cfDNA was analyzed as percentage, absolute copies/mL, and as a previously developed combined continuous model (CM) score integrating both measures to mitigate limitations of relative measurements. dd-cfDNA increased with histopathological activity and was highest in biopsies with microvascular inflammation (MVI), including antibody-mediated (AMR) and mixed rejection, paralleling high AMR/MVI and activity indices. T-cell-mediated rejection (TCMR) showed elevated TCMR/tubulointerstitial inflammation (TI) indices but lower and more variable dd-cfDNA, accompanied by increased total cfDNA, providing a plausible explanation for the reduced detectability of low-grade TCMR when dd-cfDNA is expressed as a percentage alone. Interclass correlation analyses revealed the strongest associations between dd-cfDNA and the AMR/MVI and activity indices. The combined CM score achieved the highest overall associations (sum R 2 = 3.4), outperforming absolute and relative dd-cfDNA measures. Thus, dd-cfDNA may serve as a non-invasive readout of graft inflammation and extends the rejection-continuum concept into the non-invasive space.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Heidelberg University Hospital, Heidelberg, Germany.
- Department of Nephrology and Intensive Care, Charité Universitätsmedizin Berlin, Berlin, Germany.
- Department of Nephrology and Hypertension, Klinikum Nuremberg, Paracelsus Medical University, Nuremberg, Germany.
- Chronix Biomedical GmbH, Göttingen, Germany.
- Insight Molecular Diagnostics Inc., Nashville, TN, United States.
Zitieren
APA
Benning, L., Akifova, A., Osmanodja, B., Morath, C., Beck, J., Schütz, E., & Budde, K. (2026). Donor-Derived Cell-Free DNA as a Non-Invasive Readout of Activity Across the Rejection Continuum. Transplant International, 39. https://doi.org/10.3389/ti.2026.16099
Vancouver
Benning L, Akifova A, Osmanodja B, Morath C, Beck J, Schütz E, et al. Donor-Derived Cell-Free DNA as a Non-Invasive Readout of Activity Across the Rejection Continuum. Transplant International. 2026;39. doi:10.3389/ti.2026.16099
BibTeX
@article{Benning2026,
author = {Benning, Louise and Akifova, Aylin and Osmanodja, Bilgin and Morath, Christian and Beck, Julia and Schütz, Ekkehard and Budde, Klemens},
title = {Donor-Derived Cell-Free DNA as a Non-Invasive Readout of Activity Across the Rejection Continuum},
journal = {Transplant International},
year = {2026},
volume = {39},
doi = {10.3389/ti.2026.16099}
}
EUVIMED